Novapak Prospective Observational Clinical Trial

Launched by MEDTRONIC SURGICAL TECHNOLOGIES · Feb 16, 2023

Keywords

ClinConnect Summary

The primary objective is to assess the safety of the Novapak Nasal Sinus Packing and Stent device used as indicated post-operatively in patients undergoing nasal/sinus surgery by:

* Collecting all AEs directly attributed to the device and/or those that cannot be determined; and calculating a point estimate and confidence interval
* Collecting all AEs and calculating an overall rate and safety profile for the device

The secondary objectives are to confirm device effectiveness through assessing adhesions, bleeding, healing and health during the procedure, 2 weeks and 1-month post treatment.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Subject is at least 18 years of age.
• • 2. Subject undergoing nasal/sinus surgery with the intended need for nasal sinus packing (i.e., Novapak).
• • 3. After being informed of the nature of the study; the subject understands, agrees to its provisions, is willing to participate and provide written consent.
• • 4. Mentally stable and able to follow the instructions for self-assessment/questionnaire completion.
• Exclusion Criteria:
• • 1. Subject has a shellfish allergy.
• • 2. Subject has known bleeding disorder or prescribed anticoagulants.
• • 3. Subject has craniofacial abnormalities that may interfere with access to the sinuses.
• • 4. Subject is immunocompromised (e.g., taking immunosuppressive medication).
• • 5. Subject is participating in another investigational device, biologic, or drug study and has not completed the primary endpoint(s) or if there is a potential for clinical interference beyond the primary endpoint.